期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 16, 页码 5005-5008出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm9009229
关键词
-
资金
- Sandler Foundation
- QB3-Malaysia Program
- [GM71630]
A (locking screen identified reversible, noncovalent inhibitors (e.g., I) of the parasite cysteine protease cruzain. Chemical optimization of I led to a series of oxadiazoles possessing interpretable SAR and potencies as much as 500-fold greater than 1. Detailed investigation of the SAR series subsequently revealed that many members of the oxadiazole class (and surprisingly also 1) act via divergent modes of inhibition (competitive or via colloidal aggregation) depending oil the assay conditions employed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据